Gregory Wilding, PhD (Series Introduction) Professor Department of Biostatistics School of Public Health and Health Professions Director, CTSI BERD Core Michael LaMonte, PhD, MPH (Clinical Trials ...

Medically reviewed by Kate Colby, MPH Key Takeaways In a double-blind trial, neither the patient nor the researcher knows who gets the treatment.A placebo-controlled trial uses a fake drug to test ...

Many clinical trials include a placebo group—participants who receive an inactive treatment—so researchers can compare ...

This workshop reviews the basics of Good Clinical Practice (GCP) and the recent updates that impact practice in an increasingly electronic environment. It will highlight the responsibilities the ...

Many people are surprised to learn that clinical trials aren't just for people who have run out of standard treatment options ...

A major international congress for the global pharmacology and therapeutics community, spanning both basic and clinical ...

Carrie Madormo, RN, MPH, is a health writer. She has over a decade of experience as a registered nurse, practicing in a variety of fields, such as pediatrics, oncology, chronic pain, and public health ...

With populations aging, chronic diseases becoming more prevalent, and global health experts warning of potential pandemics, the need for rapid therapeutic development has reached unprecedented levels.

This comprehensive program has been designed to be flexible and to meet the needs of the entire research team. Content is intended to address the competencies at various levels. The overall goal is to ...

Innovations in clinical trial designs and tools have the potential to unlock a new era of research that is more convenient for patients, more reflective of real-world treatment conditions, and more ...